Phase III study of KRP-114V
Phase 3
- Conditions
- Overactive bladder(OAB)
- Registration Number
- JPRN-jRCT2080222884
- Lead Sponsor
- Kyorin Pharmaceutical Co.,LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 1090
Inclusion Criteria
Patient showing clear OAB symptoms
Exclusion Criteria
Patients complicated with urinary tract infection, urinary stones, and/or interstitial cystitis
Patients with a previous history of recurrent urinary tract infection
Patients confirmed to have a post-void residual volume of more than 100 m
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method